Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 15 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
A2 MEDICALE from Elsene, company number BE0841537059, closed financial year 2025 with a result of € 6,251 after tax. For that financial year A2 MEDICALE recorded a gross margin of € 92,853 and equity of € 37,199. Compared with financial year 2024, the result moved from € 13,915 to € 6,251. The company is profitable. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 24, 2026.
€ 37,199
▲ 20% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 6,251
▼ 55% vs 2024
Profit after tax over the fiscal year.
€ 16,209
▼ 46% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 24,799.
People and assets in 2025
€ 64,327
▲ 4% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
€ 104,004
▼ 19% vs 2024
€ 24,424 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.
€ 5,831
▼ 19% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 6,601
▼ 13% vs 2024
Wages, holiday pay and social contributions still to pay. No outstanding taxes.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 108,949 | € 112,098 | € 100,775 | € 92,853 | ▼ 8% |
| Profit after taxes | € 34,354 | € 28,722 | € 13,915 | € 6,251 | ▼ 55% |
| Equity | € -11,690 | € 17,033 | € 30,948 | € 37,199 | ▲ 20% |
| Total debts | € 338,104 | € 288,903 | € 263,910 | € 236,144 | ▼ 11% |
| Cash | € 40,000 | € 31,868 | € 29,825 | € 16,209 | ▼ 46% |
| Land & buildings | € 285,209 | € 273,098 | € 260,987 | € 248,876 | ▼ 5% |
| Retained profit | € -24,090 | € 4,633 | € 18,548 | € 24,799 | ▲ 34% |
| Bank debt | € 175,296 | € 151,855 | € 128,096 | € 104,004 | ▼ 19% |
| Balance sheet total | € 326,414 | € 305,936 | € 294,858 | € 273,343 | ▼ 7% |
Key figures of A2 MEDICALE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to A2 MEDICALE?
What happened at A2 MEDICALE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 6,251 (▼ 55% vs 2024). filed late Source: NBB ↗
- Ortho Consulting became a director. NBB
- Medisleep became a director. NBB
- Start of the company according to the CBE. KBO
- New establishment in Elsene. KBO
In short
From € 34,354 profit in 2022 to € 6,251 profit in 2025.
Paid € 10,751 in corporate taxes since 2022.
Best year ever: 2022, with € 34,354 profit.
A new publication or filing at A2 MEDICALE? We notify you, reason included.
Follow A2 MEDICALEDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of ORTHO CONSULTING, MEDISLEEP comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
A2 MEDICALEBehind A2 MEDICALE are Ortho Consulting and Medisleep. The shares are held by ORTHO CONSULTING (30%) and MEDISLEEP.
Directors
According to the 2025 annual accounts
Managing director · represented by Alain Kryksztein
since 2019
Managing director · represented by Lachman Albert
since 2019
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Louizalaan 363-365 box 7
1050 Elsene
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0841.537.059
- VAT number
- BE 0841.537.059
- Registered office
- Louizalaan 363-365 bus 7, 1050 Elsene
- Names & denominations
- A2 MEDICALE
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 5 December 2011
- Peppol
- Active · Active since 18 Sept 2025
- Activities · NACE
Activiteiten van medisch specialisten
Administratieve en ondersteunende activiteiten ten behoeve van kantoren
Diverse administratieve activiteiten ten behoeve van kantoren
Handel in eigen onroerend goed